Atlas Trials

Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation.

Clinical trial NCT05048940 · WITHDRAWN

Trial details

NCT number
NCT05048940
Sponsor
Instituto de Investigación Marqués de Valdecilla
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2021-09-01
Primary completion
2021-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.